Search details
1.
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.
Mol Cancer Res
; 16(3): 496-507, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29330294
2.
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
PLoS One
; 12(8): e0182852, 2017.
Article
in English
| MEDLINE | ID: mdl-28800359
Results
1 -
2
de 2
1
Next >
>>